We are live on
!
Find out more
Beam Therapeutics
BEAM
BEAM
206 hedge funds and large institutions have $1.85B invested in Beam Therapeutics in 2023 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 77 increasing their positions, 58 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
33% more repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 58
4.17% more ownership
Funds ownership: 79.23% → 83.39% (+4.2%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
7% less first-time investments, than exits
New positions opened: 28 | Existing positions closed: 30
1% less funds holding
Funds holding: 209 → 206 (-3)
15% less capital invested
Capital invested by funds: $2.18B → $1.85B (-$330M)
34% less call options, than puts
Call options by funds: $13.2M | Put options by funds: $20.1M
Holders
206
Holders Change
-3
Holders Change %
-1.44%
% of All Funds
3.28%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
28
Increased
77
Reduced
58
Closed
30
Calls
$13.2M
Puts
$20.1M
Net Calls
-$6.94M
Net Calls Change
+$4.02M
Top Buyers
Top Sellers
| 1 |
Goldman Sachs
New York
|
-$14.2M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
-$6.25M |
| 3 |
Renaissance Technologies
New York
|
-$5.16M |
| 4 |
CAI
Capital Advisors Inc
Tulsa,
Oklahoma
|
-$4.24M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$4.09M |
